Cell Therapy Market

Global Cell Therapy Market by Use (Clinical Use, Research Use), Therapy Type (Allogenic Therapies, Autologous Therapies) and Region - 2022 to 2032

Newly-released cell therapy market analysis report by Transparency Market Research shows that global sales of the Market in 2021 were held at US$ 8.5 Bn. With 18.7%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. Autologous Therapies of cell therapy are expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 18% from 2022 – to 2032.

Revenue of Cell Therapy Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Market increased at around 16% CAGR.

Cell and gene therapy-based products have the potential to be a viable and disease-modifying treatment for diseases that would otherwise be incurable with conventional medicines. Another factor driving market expansion is the increased usage of cell therapy products in hospitalized patients to treat burns, venous leg ulcers, diabetic foot ulcers, traumas, and pressure ulcers. According to the American College of Surgeons, 1–2% of the worldwide population will develop chronic wounds over their lives.

As per the Centre for Disease Control and Prevention (CDC), six out of ten individuals in the United States have a chronic disease, and four out of ten persons have two or more chronic diseases. As a result, the demand for various cellular treatments, such as transfusion, immune cell therapy, and stem cell therapy, among others, is increasing among healthcare professionals.

According to statistics from the American National Red Cross, around 21 million blood transfusions are transfused in the United States each year. Furthermore, according to the Health Resources and Services Administration (HSRA), there were 4992 unconnected and 4275 related bone marrow and umbilical cord blood transplants in the United States in 2018.

What Factors are Propelling Cell Therapy Demand?

Cell and gene therapies (CGTs) are at the cutting edge of technology in the treatment of both severe and uncommon illnesses. LUXTURNA, a therapy for a hereditary retinal illness that causes blindness, is one of several such medicines presently on the market.

CGT marks a prominent medical breakthrough as it was the first curative gene therapy to be licensed for use. In August 2020, the FDA approved Novartis' Kymriah regenerative medicine for improved therapy in the treatment of adult patients with refractory follicular lymphoma. In July 2020, the FDA approved brexucabtagene Acelus, a CAR T-cell treatment for patients with mantle cell lymphoma.

Many additional CGTs are currently being developed. As of June 2020, more than 750 CGT studies in about 30,000 patients were underway, and CGT drugs represent approximately 12% of the pharmaceutical industry's clinical pipeline and at least 16% of its preclinical pipeline. The general need for novel, more effective treatments like cancer therapy and cardiovascular disease has spurred research into solutions via cell-based research, whereas the Australian government released a new Cell Therapies Mission in November 2019.

Under the Medical Research Future Fund (MRFF), the project would provide US$ 102 million to incentivize stem cell research to develop novel medicines. Similarly, Foster innovation UK, the UK's technology agency was awarded GBP 267,000 in financing in September 2019 to foster gel stabilization technology created by Atelerix, with the first goal of winning.

How has the Large Scale Production boosted the Growth Trigger in the Market for Cell Therapy?

The majority of medicinal cell manufacturing procedures have been designed using a cell biology-driven strategy, which is critical in the early stages of research. However, for reliable and standardized production in a maturing area, a highly regulated manufacturing engineering plan with automation, process monitoring, and control to improve batch efficiency and consistency is required.

Over 900 companies are now committed to the study and manufacture of cell-based medicinal products, ranging from small and medium-sized businesses to international organizations.

To create cells in volumes that match therapeutic demands, a scalable method for multipotent cell growth and differentiation is necessary. Aside from quantity, the manufacturing method must adhere to good manufacturing principles (GMP) and enable the culture to be performed under controlled, serum-free, and Xeno-free conditions. In scalability, simplicity of design, and ease of handling, cell culture in bioreactors is the most advantageous culture option for large manufacturing.

Which Region is projected to Offer the Largest Opportunity for the Market?

In 2021, North America held the largest share of the global cancer therapy market. Government support for the healthcare sector's development, a high level of awareness about rare disorders, easy access to high-quality medical facilities, and reimbursement policies are some of the key drivers for regional market growth.

Between 2013 and 2017, there were 75,497 new cases of MDS Myelodysplastic Syndromes in North America, with an average of 15,099 cases each year. In North America, an estimated 58,471 persons have MDS or are in remission. MDS has a 5-year relative survival rate of 38.3% from 2010 to 2016.

One in every three individuals has more than one chronic ailment or many chronic conditions. Cell therapy developers are being supported by both the public and business sectors. In terms of R&D activity and financing to develop and market cell and gene therapy products, North America is at the forefront.

For example, the Alliance for Cancer Gene Therapy provides Young Investigator and Clinical Translation funding ranging from US$ 250,000 to US$ 500,000 over a period of three to five years, with a maximum limit of 10 indirect expenses. The California Institute of Regenerative Medicine and the National Heart, Lung, and Blood Institute formed a partnership in May 2019, co-funded, and expedite the discovery of cancer treatments.

Country-wise Analysis

U.S. Market Analysis

The United States is at the forefront of research in biomedical and technological advancement. Someone in the United States suffers from a blood malignancy every 9 minutes. This figure equates to nearly 158 individuals each day or more than six people per hour. In the United States, leukemia, lymphoma, and myeloma are anticipated to kill 57,750 individuals in 2021.

Based on a projected total of 608,570 cancer deaths, these illnesses are predicted to account for 9.5% of cancer deaths in 2021. The United States has been a driving force behind the development of a stem cell and cell-based therapeutic 'tourist' sector.

It is estimated that 350 stem cell clinics for chronic illnesses like leukemia throughout the world receive an average of five tourists per month, resulting in 21,000 stem cell and cell therapy medical tourists every year out of a total of 3,000,000 medical tourists. This accounts for around 0.7% of the total medical travel patient flow and about 3% of overall revenue.

The U.K. Market Analysis

The market for cell therapy in the U.K. is expected to reach a valuation of US$ 2.2 Bn by 2032. With a CAGR of 21.4% during 2022 – 2032, the market is expected to gross an absolute dollar opportunity of around US$ 2 Bn.

Japan Market Analysis

In Japan, the market for cell therapy grew at a CAGR of 16.7% during 2017 – 2021. The market is expected to reach a valuation of US$ 2.5 Bn, growing at a CAGR of 20.5%. The market is expected to gross an absolute dollar opportunity of US$ 2.1 Bn during the forecast period.

South Korea Market Analysis

The market for cell therapy in South Korea is expected to reach a valuation of US$ 1 Bn by 2032. Growing at a CAGR of 18% during the forecast period, the market is projected to gross an absolute dollar opportunity of US$ 823 Mn.

Category-wise Insights

Why Research used is projected to Witness the Fastest Growth among Cell Therapy Types?

The research-use type of cell therapy market accounted for a CAGR of 18.2% of total revenue in the forecast period. Research initiatives are the ones that most accounted for stem cells, which resulted in a substantial revenue share for the research-use sector. Several stem cell-based therapies have been licensed for clinical studies by the Food and Drug Administration (FDA).

According to a 2013 study from the Pharmaceutical Research and Manufacturers of America, 69 cell treatments are undergoing FDA clinical trials, with 15 of them in phase 3. Cardiovascular disease, skin illnesses, cancer, and associated ailments, digestive problems, transplant, genetic problems, musculoskeletal disorders, and eye issues are among the therapeutic categories covered in these studies.

Which Component of Cell Therapy is expected to Score Highest Growth in the Coming Years?

Autologous Therapies commanded the largest revenue as well as a CAGR of 18.2%, during the forecast period. Autologous fat grafts were used for aesthetic purposes for over a century. Severe, partial, and filled burns have all been treated with autologous keratinocytes. Autologous human fibroblasts are beneficial in the treatment of wrinkles, rhytids, and acne scars.

These cells are in charge of the extracellular environment's production and secretion (collagen, elastin, hyaluronic acid, and glycosaminoglycans) and, when injected, may detect and restore self-diminished regions in the dermis.

Competitive Analysis

Some of the key companies operating in the cell therapy market include Novartis AG, Pharmicell, Osiris Therapeutics (Smith & Nephew), GlaxoSmithKline, Anterogen, IMFS, Stemedica Cell Technologies, NuVasive, BioNTech, Kolon TissueGene, JCR Pharmaceuticals, Cells for Cells, and Vericel Corporation.

Some of the recent developments of key cell therapy providers are as follows:

  • In April 2019, Hitachi Chemical Co. Ltd. bought apceth Biopharma GmbH to expand its foothold in the contract development and manufacturing organization (CDMO) industry for gene and cell therapies production.
  • In June 2021, Charles River Laboratories acquired a cellular and gene therapy contract manufacturer-to-manufacturing capabilities through the acquisition of CDMO Cognate BioServices.
  • In August 2021, Thermo Fisher Scientific paid US$ 859.7 million for Henogen S.A., Novasep's viral vector production firm in Belgium. This purchase strengthens its position in the cell and gene therapy manufacturing therapeutic sector.
  • In July 2019, Thermo Fisher Scientific paid US$ 1.7 billion for Brammer Bio, a business that manufactures viral vectors for gene and cell treatments.

Similarly, recent developments related to companies in Cell Therapy services have been tracked by the team at Transparency Market Research, which is available in the full report.

Market Segments Covered in Cell Therapy Market Analysis

By Use Type

  • Clinical use
    • Therapeutic Area
    • Cell Type
  • Research Use

By Therapy Type

  • Allogenic Therapies
  • Autologous Therapies

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Market Snapshot

Attribute

Details

Global Cell Therapy Market (2022)

US$ 10 Bn

Global Cell Therapy Industry (2032)

US$ 54.6 Bn

Global Market CAGR (2022 – 2032)

18.7%

U.S. Cell Therapy Market CAGR (2022 – 2032)

18.3%

Key Companies Profiled

  • Smith & Nephew
  • NuVasive
  • Bristol-Myers Squibb Company
  • Kolon Tissue Gene
  • JCR Pharmaceuticals
  • Cells for Cells
  • Hitachi Chemical Co Ltd
  • Thermo Fisher Scientific
  • Charles River Laboratories

 

Frequently Asked Questions

What is the current worth of the Cell Therapy Market?

The global Market is worth more than US$ 8.5 Bn at present.

What is the sales forecast for Market?

The value of Market is projected to increase at a CAGR of around 18.7% from 2022 – to 2032.

What was the last 5 year’s market CAGR?

The value of the Market increased at a CAGR of around 16% from 2017 – to 2021.

What is a key trend shaping the growth of the global market for Cell Therapy?

Continuous advances in cell therapy have led to the use of several types of stem cells in the treatment of a wide range of disorders, including dendritic cells, mesenchymal stem cells, skeletal muscle stem cells, hematopoietic stem cells, and lymphocytes.

At what percentage is sales of the Cell Therapy Industry going to register growth in China?

The market for Cell Therapy in China is projected to expand at a CAGR of around 20.8% from 2022 – to 2032.

What do statistics for South Korea and Japan reveal?

While the market in South Korea is expected to grow at nearly 18%, the market in Japan is projected to register a CAGR of nearly 20.5% from 2022 – to 2032.

    1. Executive Summary

        1.1. Global Market Outlook

        1.2. Demand-side Trends

        1.3. Supply-side Trends

        1.4. Technology Roadmap Analysis

        1.5. Analysis and Recommendations

    2. Market Overview

        2.1. Market Coverage / Taxonomy

        2.2. Market Definition / Scope / Limitations

    3. Market Background

        3.1. Market Dynamics

            3.1.1. Drivers

            3.1.2. Restraints

            3.1.3. Opportunity

            3.1.4. Trends

        3.2. Scenario Forecast

            3.2.1. Demand in Optimistic Scenario

            3.2.2. Demand in Likely Scenario

            3.2.3. Demand in Conservative Scenario

        3.3. Opportunity Map Analysis

        3.4. Product Life Cycle Analysis

        3.5. Investment Feasibility Matrix

        3.6. PESTLE and Porter’s Analysis

        3.7. Regulatory Landscape

            3.7.1. By Key Regions

            3.7.2. By Key Countries

        3.8. Regional Parent Market Outlook

    4. Global Cell Therapy Market Analysis 2017-2021 and Forecast, 2022-2032

        4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

        4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

            4.2.1. Y-o-Y Growth Trend Analysis

            4.2.2. Absolute $ Opportunity Analysis

    5. Global Cell Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By Use-type

        5.1. Introduction / Key Findings

        5.2. Historical Market Size Value (US$ Mn) Analysis By Use-type, 2017-2021

        5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Use-type, 2022-2032

            5.3.1. Clinical-use

                5.3.1.1. Therapeutic Area

                5.3.1.2. Cell Type

            5.3.2. Research-use

        5.4. Y-o-Y Growth Trend Analysis By Use-type, 2017-2021

        5.5. Absolute $ Opportunity Analysis By Use-type, 2022-2032

    6. Global Cell Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By Therapy Type

        6.1. Introduction / Key Findings

        6.2. Historical Market Size Value (US$ Mn) Analysis By Therapy Type, 2017-2021

        6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Therapy Type, 2022-2032

            6.3.1. Allogenic Therapies

            6.3.2. Autologous Therapies

        6.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2017-2021

        6.5. Absolute $ Opportunity Analysis By Therapy Type, 2022-2032

    7. Global Cell Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By Region

        7.1. Introduction

        7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

        7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

            7.3.1. North America

            7.3.2. Latin America

            7.3.3. Europe

            7.3.4. Asia Pacific

            7.3.5. Middle East and Africa

        7.4. Market Attractiveness Analysis By Region

    8. North America Cell Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By Country

        8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

        8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

            8.2.1. By Country

                8.2.1.1. U.S.

                8.2.1.2. Canada

            8.2.2. By Use-type

            8.2.3. By Therapy Type

        8.3. Market Attractiveness Analysis

            8.3.1. By Country

            8.3.2. By Use-type

            8.3.3. By Therapy Type

        8.4. Key Takeaways

    9. Latin America Cell Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By Country

        9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

        9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

            9.2.1. By Country

                9.2.1.1. Brazil

                9.2.1.2. Mexico

                9.2.1.3. Rest of Latin America

            9.2.2. By Use-type

            9.2.3. By Therapy Type

        9.3. Market Attractiveness Analysis

            9.3.1. By Country

            9.3.2. By Use-type

            9.3.3. By Therapy Type

        9.4. Key Takeaways

    10. Europe Cell Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By Country

        10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

        10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

            10.2.1. By Country

                10.2.1.1. Germany

                10.2.1.2. U.K.

                10.2.1.3. France

                10.2.1.4. Spain

                10.2.1.5. Italy

                10.2.1.6. Russia

                10.2.1.7. Rest of Europe

            10.2.2. By Use-type

            10.2.3. By Therapy Type

        10.3. Market Attractiveness Analysis

            10.3.1. By Country

            10.3.2. By Use-type

            10.3.3. By Therapy Type

        10.4. Key Takeaways

    11. Asia Pacific Cell Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By Country

        11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

        11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

            11.2.1. By Country

                11.2.1.1. China

                11.2.1.2. Japan

                11.2.1.3. India

                11.2.1.4. South Korea

                11.2.1.5. Australia

                11.2.1.6. Rest of APAC

            11.2.2. By Use-type

            11.2.3. By Therapy Type

        11.3. Market Attractiveness Analysis

            11.3.1. By Country

            11.3.2. By Use-type

            11.3.3. By Therapy Type

        11.4. Key Takeaways

    12. Middle East and Africa Cell Therapy Market Analysis 2017-2021 and Forecast 2022-2032, By Country

        12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

        12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

            12.2.1. By Country

                12.2.1.1. South Africa

                12.2.1.2. Saudi Arabia

                12.2.1.3. UAE

                12.2.1.4. Israel

                12.2.1.5. Rest of MEA

            12.2.2. By Use-type

            12.2.3. By Therapy Type

        12.3. Market Attractiveness Analysis

            12.3.1. By Country

            12.3.2. By Use-type

            12.3.3. By Therapy Type

        12.4. Key Takeaways

    13. Key Countries Cell Therapy Market Analysis

        13.1. U.S.

            13.1.1. Pricing Analysis

            13.1.2. Market Share Analysis, 2021

                13.1.2.1. By Use-type

                13.1.2.2. By Therapy Type

        13.2. Canada

            13.2.1. Pricing Analysis

            13.2.2. Market Share Analysis, 2021

                13.2.2.1. By Use-type

                13.2.2.2. By Therapy Type

        13.3. Brazil

            13.3.1. Pricing Analysis

            13.3.2. Market Share Analysis, 2021

                13.3.2.1. By Use-type

                13.3.2.2. By Therapy Type

        13.4. Mexico

            13.4.1. Pricing Analysis

            13.4.2. Market Share Analysis, 2021

                13.4.2.1. By Use-type

                13.4.2.2. By Therapy Type

        13.5. Germany

            13.5.1. Pricing Analysis

            13.5.2. Market Share Analysis, 2021

                13.5.2.1. By Use-type

                13.5.2.2. By Therapy Type

        13.6. U.K.

            13.6.1. Pricing Analysis

            13.6.2. Market Share Analysis, 2021

                13.6.2.1. By Use-type

                13.6.2.2. By Therapy Type

        13.7. France

            13.7.1. Pricing Analysis

            13.7.2. Market Share Analysis, 2021

                13.7.2.1. By Use-type

                13.7.2.2. By Therapy Type

        13.8. Spain

            13.8.1. Pricing Analysis

            13.8.2. Market Share Analysis, 2021

                13.8.2.1. By Use-type

                13.8.2.2. By Therapy Type

        13.9. Italy

            13.9.1. Pricing Analysis

            13.9.2. Market Share Analysis, 2021

                13.9.2.1. By Use-type

                13.9.2.2. By Therapy Type

        13.10. Russia

            13.10.1. Pricing Analysis

            13.10.2. Market Share Analysis, 2021

                13.10.2.1. By Use-type

                13.10.2.2. By Therapy Type

        13.11. China

            13.11.1. Pricing Analysis

            13.11.2. Market Share Analysis, 2021

                13.11.2.1. By Use-type

                13.11.2.2. By Therapy Type

        13.12. Japan

            13.12.1. Pricing Analysis

            13.12.2. Market Share Analysis, 2021

                13.12.2.1. By Use-type

                13.12.2.2. By Therapy Type

        13.13. India

            13.13.1. Pricing Analysis

            13.13.2. Market Share Analysis, 2021

                13.13.2.1. By Use-type

                13.13.2.2. By Therapy Type

        13.14. South Korea

            13.14.1. Pricing Analysis

            13.14.2. Market Share Analysis, 2021

                13.14.2.1. By Use-type

                13.14.2.2. By Therapy Type

        13.15. Australia

            13.15.1. Pricing Analysis

            13.15.2. Market Share Analysis, 2021

                13.15.2.1. By Use-type

                13.15.2.2. By Therapy Type

        13.16. South Africa

            13.16.1. Pricing Analysis

            13.16.2. Market Share Analysis, 2021

                13.16.2.1. By Use-type

                13.16.2.2. By Therapy Type

        13.17. Saudi Arabia

            13.17.1. Pricing Analysis

            13.17.2. Market Share Analysis, 2021

                13.17.2.1. By Use-type

                13.17.2.2. By Therapy Type

        13.18. UAE

            13.18.1. Pricing Analysis

            13.18.2. Market Share Analysis, 2021

                13.18.2.1. By Use-type

                13.18.2.2. By Therapy Type

        13.19. Israel

            13.19.1. Pricing Analysis

            13.19.2. Market Share Analysis, 2021

                13.19.2.1. By Use-type

                13.19.2.2. By Therapy Type

    14. Market Structure Analysis

        14.1. Competition Dashboard

        14.2. Competition Benchmarking

        14.3. Market Share Analysis of Top Players

            14.3.1. By Regional

            14.3.2. By Use-type

            14.3.3. By Therapy Type

    15. Competition Analysis

        15.1. Competition Deep Dive

            15.1.1. Kolon TissueGene, Inc.

                15.1.1.1. Overview

                15.1.1.2. Product Portfolio

                15.1.1.3. Profitability by Market Segments

                15.1.1.4. Sales Footprint

                15.1.1.5. Strategy Overview

                    15.1.1.5.1. Marketing Strategy

            15.1.2. JCR Pharmaceuticals Co., Ltd.

                15.1.2.1. Overview

                15.1.2.2. Product Portfolio

                15.1.2.3. Profitability by Market Segments

                15.1.2.4. Sales Footprint

                15.1.2.5. Strategy Overview

                    15.1.2.5.1. Marketing Strategy

            15.1.3. Medipost Co Ltd

                15.1.3.1. Overview

                15.1.3.2. Product Portfolio

                15.1.3.3. Profitability by Market Segments

                15.1.3.4. Sales Footprint

                15.1.3.5. Strategy Overview

                    15.1.3.5.1. Marketing Strategy

            15.1.4. Smith & Nephew

                15.1.4.1. Overview

                15.1.4.2. Product Portfolio

                15.1.4.3. Profitability by Market Segments

                15.1.4.4. Sales Footprint

                15.1.4.5. Strategy Overview

                    15.1.4.5.1. Marketing Strategy

            15.1.5. Stemedica Cell Technologies, Inc.

                15.1.5.1. Overview

                15.1.5.2. Product Portfolio

                15.1.5.3. Profitability by Market Segments

                15.1.5.4. Sales Footprint

                15.1.5.5. Strategy Overview

                    15.1.5.5.1. Marketing Strategy

            15.1.6. NuVasive, Inc.

                15.1.6.1. Overview

                15.1.6.2. Product Portfolio

                15.1.6.3. Profitability by Market Segments

                15.1.6.4. Sales Footprint

                15.1.6.5. Strategy Overview

                    15.1.6.5.1. Marketing Strategy

            15.1.7. Castle Creek Biosciences, Inc.

                15.1.7.1. Overview

                15.1.7.2. Product Portfolio

                15.1.7.3. Profitability by Market Segments

                15.1.7.4. Sales Footprint

                15.1.7.5. Strategy Overview

                    15.1.7.5.1. Marketing Strategy

            15.1.8. Vericel Corporation

                15.1.8.1. Overview

                15.1.8.2. Product Portfolio

                15.1.8.3. Profitability by Market Segments

                15.1.8.4. Sales Footprint

                15.1.8.5. Strategy Overview

                    15.1.8.5.1. Marketing Strategy

            15.1.9. Pharmicell

                15.1.9.1. Overview

                15.1.9.2. Product Portfolio

                15.1.9.3. Profitability by Market Segments

                15.1.9.4. Sales Footprint

                15.1.9.5. Strategy Overview

                    15.1.9.5.1. Marketing Strategy

            15.1.10. Anterogen Co Ltd

                15.1.10.1. Overview

                15.1.10.2. Product Portfolio

                15.1.10.3. Profitability by Market Segments

                15.1.10.4. Sales Footprint

                15.1.10.5. Strategy Overview

                    15.1.10.5.1. Marketing Strategy

            15.1.11. Bristol-Myers Squibb Company

                15.1.11.1. Overview

                15.1.11.2. Product Portfolio

                15.1.11.3. Profitability by Market Segments

                15.1.11.4. Sales Footprint

                15.1.11.5. Strategy Overview

                    15.1.11.5.1. Marketing Strategy

    16. Assumptions & Acronyms Used

    17. Research Methodology

    List of Tables

    Table 1: Global Cell Therapy Market Value (US$ Mn) Forecast by Region, 2017-2032

    Table 2: Global Cell Therapy Market Value (US$ Mn) Forecast by Use-type, 2017-2032

    Table 3: Global Cell Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

    Table 4: North America Cell Therapy Market Value (US$ Mn) Forecast by Country, 2017-2032

    Table 5: North America Cell Therapy Market Value (US$ Mn) Forecast by Use-type, 2017-2032

    Table 6: North America Cell Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

    Table 7: Latin America Cell Therapy Market Value (US$ Mn) Forecast by Country, 2017-2032

    Table 8: Latin America Cell Therapy Market Value (US$ Mn) Forecast by Use-type, 2017-2032

    Table 9: Latin America Cell Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

    Table 10: Europe Cell Therapy Market Value (US$ Mn) Forecast by Country, 2017-2032

    Table 11: Europe Cell Therapy Market Value (US$ Mn) Forecast by Use-type, 2017-2032

    Table 12: Europe Cell Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

    Table 13: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast by Country, 2017-2032

    Table 14: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast by Use-type, 2017-2032

    Table 15: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

    Table 16: Middle East and Africa Cell Therapy Market Value (US$ Mn) Forecast by Country, 2017-2032

    Table 17: Middle East and Africa Cell Therapy Market Value (US$ Mn) Forecast by Use-type, 2017-2032

    Table 18: Middle East and Africa Cell Therapy Market Value (US$ Mn) Forecast by Therapy Type, 2017-2032

    List of Figures

    Figure 1: Global Cell Therapy Market Value (US$ Mn) by Use-type, 2022-2032

    Figure 2: Global Cell Therapy Market Value (US$ Mn) by Therapy Type, 2022-2032

    Figure 3: Global Cell Therapy Market Value (US$ Mn) by Region, 2022-2032

    Figure 4: Global Cell Therapy Market Value (US$ Mn) Analysis by Region, 2017-2032

    Figure 5: Global Cell Therapy Market Value Share (%) and BPS Analysis by Region, 2022-2032

    Figure 6: Global Cell Therapy Market Y-o-Y Growth (%) Projections by Region, 2022-2032

    Figure 7: Global Cell Therapy Market Value (US$ Mn) Analysis by Use-type, 2017-2032

    Figure 8: Global Cell Therapy Market Value Share (%) and BPS Analysis by Use-type, 2022-2032

    Figure 9: Global Cell Therapy Market Y-o-Y Growth (%) Projections by Use-type, 2022-2032

    Figure 10: Global Cell Therapy Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

    Figure 11: Global Cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

    Figure 12: Global Cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

    Figure 13: Global Cell Therapy Market Attractiveness by Use-type, 2022-2032

    Figure 14: Global Cell Therapy Market Attractiveness by Therapy Type, 2022-2032

    Figure 15: Global Cell Therapy Market Attractiveness by Region, 2022-2032

    Figure 16: North America Cell Therapy Market Value (US$ Mn) by Use-type, 2022-2032

    Figure 17: North America Cell Therapy Market Value (US$ Mn) by Therapy Type, 2022-2032

    Figure 18: North America Cell Therapy Market Value (US$ Mn) by Country, 2022-2032

    Figure 19: North America Cell Therapy Market Value (US$ Mn) Analysis by Country, 2017-2032

    Figure 20: North America Cell Therapy Market Value Share (%) and BPS Analysis by Country, 2022-2032

    Figure 21: North America Cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2022-2032

    Figure 22: North America Cell Therapy Market Value (US$ Mn) Analysis by Use-type, 2017-2032

    Figure 23: North America Cell Therapy Market Value Share (%) and BPS Analysis by Use-type, 2022-2032

    Figure 24: North America Cell Therapy Market Y-o-Y Growth (%) Projections by Use-type, 2022-2032

    Figure 25: North America Cell Therapy Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

    Figure 26: North America Cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

    Figure 27: North America Cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

    Figure 28: North America Cell Therapy Market Attractiveness by Use-type, 2022-2032

    Figure 29: North America Cell Therapy Market Attractiveness by Therapy Type, 2022-2032

    Figure 30: North America Cell Therapy Market Attractiveness by Country, 2022-2032

    Figure 31: Latin America Cell Therapy Market Value (US$ Mn) by Use-type, 2022-2032

    Figure 32: Latin America Cell Therapy Market Value (US$ Mn) by Therapy Type, 2022-2032

    Figure 33: Latin America Cell Therapy Market Value (US$ Mn) by Country, 2022-2032

    Figure 34: Latin America Cell Therapy Market Value (US$ Mn) Analysis by Country, 2017-2032

    Figure 35: Latin America Cell Therapy Market Value Share (%) and BPS Analysis by Country, 2022-2032

    Figure 36: Latin America Cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2022-2032

    Figure 37: Latin America Cell Therapy Market Value (US$ Mn) Analysis by Use-type, 2017-2032

    Figure 38: Latin America Cell Therapy Market Value Share (%) and BPS Analysis by Use-type, 2022-2032

    Figure 39: Latin America Cell Therapy Market Y-o-Y Growth (%) Projections by Use-type, 2022-2032

    Figure 40: Latin America Cell Therapy Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

    Figure 41: Latin America Cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

    Figure 42: Latin America Cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

    Figure 43: Latin America Cell Therapy Market Attractiveness by Use-type, 2022-2032

    Figure 44: Latin America Cell Therapy Market Attractiveness by Therapy Type, 2022-2032

    Figure 45: Latin America Cell Therapy Market Attractiveness by Country, 2022-2032

    Figure 46: Europe Cell Therapy Market Value (US$ Mn) by Use-type, 2022-2032

    Figure 47: Europe Cell Therapy Market Value (US$ Mn) by Therapy Type, 2022-2032

    Figure 48: Europe Cell Therapy Market Value (US$ Mn) by Country, 2022-2032

    Figure 49: Europe Cell Therapy Market Value (US$ Mn) Analysis by Country, 2017-2032

    Figure 50: Europe Cell Therapy Market Value Share (%) and BPS Analysis by Country, 2022-2032

    Figure 51: Europe Cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2022-2032

    Figure 52: Europe Cell Therapy Market Value (US$ Mn) Analysis by Use-type, 2017-2032

    Figure 53: Europe Cell Therapy Market Value Share (%) and BPS Analysis by Use-type, 2022-2032

    Figure 54: Europe Cell Therapy Market Y-o-Y Growth (%) Projections by Use-type, 2022-2032

    Figure 55: Europe Cell Therapy Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

    Figure 56: Europe Cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

    Figure 57: Europe Cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

    Figure 58: Europe Cell Therapy Market Attractiveness by Use-type, 2022-2032

    Figure 59: Europe Cell Therapy Market Attractiveness by Therapy Type, 2022-2032

    Figure 60: Europe Cell Therapy Market Attractiveness by Country, 2022-2032

    Figure 61: Asia Pacific Cell Therapy Market Value (US$ Mn) by Use-type, 2022-2032

    Figure 62: Asia Pacific Cell Therapy Market Value (US$ Mn) by Therapy Type, 2022-2032

    Figure 63: Asia Pacific Cell Therapy Market Value (US$ Mn) by Country, 2022-2032

    Figure 64: Asia Pacific Cell Therapy Market Value (US$ Mn) Analysis by Country, 2017-2032

    Figure 65: Asia Pacific Cell Therapy Market Value Share (%) and BPS Analysis by Country, 2022-2032

    Figure 66: Asia Pacific Cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2022-2032

    Figure 67: Asia Pacific Cell Therapy Market Value (US$ Mn) Analysis by Use-type, 2017-2032

    Figure 68: Asia Pacific Cell Therapy Market Value Share (%) and BPS Analysis by Use-type, 2022-2032

    Figure 69: Asia Pacific Cell Therapy Market Y-o-Y Growth (%) Projections by Use-type, 2022-2032

    Figure 70: Asia Pacific Cell Therapy Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

    Figure 71: Asia Pacific Cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

    Figure 72: Asia Pacific Cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

    Figure 73: Asia Pacific Cell Therapy Market Attractiveness by Use-type, 2022-2032

    Figure 74: Asia Pacific Cell Therapy Market Attractiveness by Therapy Type, 2022-2032

    Figure 75: Asia Pacific Cell Therapy Market Attractiveness by Country, 2022-2032

    Figure 76: Middle East and Africa Cell Therapy Market Value (US$ Mn) by Use-type, 2022-2032

    Figure 77: Middle East and Africa Cell Therapy Market Value (US$ Mn) by Therapy Type, 2022-2032

    Figure 78: Middle East and Africa Cell Therapy Market Value (US$ Mn) by Country, 2022-2032

    Figure 79: Middle East and Africa Cell Therapy Market Value (US$ Mn) Analysis by Country, 2017-2032

    Figure 80: Middle East and Africa Cell Therapy Market Value Share (%) and BPS Analysis by Country, 2022-2032

    Figure 81: Middle East and Africa Cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2022-2032

    Figure 82: Middle East and Africa Cell Therapy Market Value (US$ Mn) Analysis by Use-type, 2017-2032

    Figure 83: Middle East and Africa Cell Therapy Market Value Share (%) and BPS Analysis by Use-type, 2022-2032

    Figure 84: Middle East and Africa Cell Therapy Market Y-o-Y Growth (%) Projections by Use-type, 2022-2032

    Figure 85: Middle East and Africa Cell Therapy Market Value (US$ Mn) Analysis by Therapy Type, 2017-2032

    Figure 86: Middle East and Africa Cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2022-2032

    Figure 87: Middle East and Africa Cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2022-2032

    Figure 88: Middle East and Africa Cell Therapy Market Attractiveness by Use-type, 2022-2032

    Figure 89: Middle East and Africa Cell Therapy Market Attractiveness by Therapy Type, 2022-2032

    Figure 90: Middle East and Africa Cell Therapy Market Attractiveness by Country, 2022-2032

Copyright © Transparency Market Research, Inc. All Rights reserved